Prime Medicine, Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 48.77 | -100% | -10.33 | -100% |
| P/S |
|
120.86 | 33.77 | 257.94% |
|
|
| P/BV |
|
6.29 | 4.83 | 30.27% |
|
|
| P/FCF |
|
-6.66 | 61 | -110.92% |
|
|
| Ev/Ebitda |
|
-4.33 | -22.17 | -80.45% |
|
|
| Ev/S |
|
155.57 | 22.57 | 589.2% |
|
|
| Ev/FCF |
|
-4.65 | 68.76 | -106.76% |
|
|
| E/P |
|
-0.1708 | 0.0178 | -1060.97% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
-2080.92 | 4.97 | -41952.19% | -783.82 | +165.48% |
| ROE |
|
-148.89 | 9.61 | -1649.1% |
|
|
| ROA |
|
-102.21 | 0.3443 | -29789.5% |
|
|
| ROIC |
|
0 | 7.63 | -100% |
|
|
| ROS |
|
-3810.25 | -25.17 | 15037.99% |
|
|
| ROCE |
|
-143.75 | 15.45 | -1030.46% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.073 | -3.68 | -98.01% | -0.1201 | -39.19% |
| Nеt Debt/Ebitda |
|
0.1497 | -3.44 | -104.36% |
|
|
| Debt/Ratio |
|
0.0703 | 0.1986 | -64.59% |
|
|
| Debt/Equity |
|
0.7175 | 1.66 | -56.84% |
|
|
| Debt/Net Income |
|
-0.0688 | 10.32 | -100.67% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.541 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.7368 | -100% | ||
| DSI |
|
0 | 0.2256 | -100% |
|
|
| Average dividend growth |
|
0 | 0.9598 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.4928 | -100% |
|
|
| Average percentage for payments |
|
0 | 43.56 | -100% |
|
|
| Difference from average difference in sector |
|
-0.541 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
1/10
|
0.1923 | -57.64 | -100.33% | ||
| Growth impulse Ebitda in 5 years |
|
8707.23 | -90.94 | -9674.7% | ||
| Growth impulse Net Income in 5 years |
|
7825.32 | -97.8 | -8101.35% | ||
| Growth impulse FCF in 5 years |
|
13295.08 | -108.72 | -12328.73% | ||
| Growth impulse EPS in 5 years |
|
8150.08 | -142.05 | -5837.47% |
IP Score
4.15/10
